 |
PDBsum entry 3cqu
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
18:3359-3363
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Synthesis and structure based optimization of novel Akt inhibitors.
|
|
B.Lippa,
G.Pan,
M.Corbett,
C.Li,
G.S.Kauffman,
J.Pandit,
S.Robinson,
L.Wei,
E.Kozina,
E.S.Marr,
G.Borzillo,
E.Knauth,
E.G.Barbacci-Tobin,
P.Vincent,
M.Troutman,
D.Baker,
F.Rajamohan,
S.Kakar,
T.Clark,
J.Morris.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Based on a high throughput screening hit, pyrrolopyrimidine inhibitors of the
Akt kinase are explored. X-ray co-crystal structures of two lead series results
in the understanding of key binding interactions, the design of new lead series,
and enhanced potency. The syntheses of these series and their biological
activities are described. Spiroindoline 13j is found to have an Akt1 kinase
IC(50) of 2.4+/-0.6 nM, Akt cell potency of 50+/-19 nM, and provides 68%
inhibition of tumor growth in a mouse xenograft model (50 mg/kg, qd, po).
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
R.Xu,
A.Banka,
J.F.Blake,
I.S.Mitchell,
E.M.Wallace,
J.R.Bencsik,
N.C.Kallan,
K.L.Spencer,
S.L.Gloor,
M.Martinson,
T.Risom,
S.D.Gross,
T.H.Morales,
W.I.Wu,
G.P.Vigers,
B.J.Brandhuber,
and
N.J.Skelton
(2011).
Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA.
|
| |
Bioorg Med Chem Lett,
21,
2335-2340.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Del Rio,
A.J.Barbosa,
F.Caporuscio,
and
G.F.Mangiatordi
(2010).
CoCoCo: a free suite of multiconformational chemical databases for high-throughput virtual screening purposes.
|
| |
Mol Biosyst,
6,
2122-2128.
|
 |
|
|
|
|
 |
T.McHardy,
J.J.Caldwell,
K.M.Cheung,
L.J.Hunter,
K.Taylor,
M.Rowlands,
R.Ruddle,
A.Henley,
A.de Haven Brandon,
M.Valenti,
T.G.Davies,
L.Fazal,
L.Seavers,
F.I.Raynaud,
S.A.Eccles,
G.W.Aherne,
M.D.Garrett,
and
I.Collins
(2010).
Discovery of 4-amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides as selective, orally active inhibitors of protein kinase B (Akt).
|
| |
J Med Chem,
53,
2239-2249.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
W.I.Wu,
W.C.Voegtli,
H.L.Sturgis,
F.P.Dizon,
G.P.Vigers,
and
B.J.Brandhuber
(2010).
Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition.
|
| |
PLoS One,
5,
e12913.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |